News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Farina Arreguin: Chemo-Immunotherapy Has Improved the Care of Patients With Relapsed/Refractory Neuroblastoma
Farina Arreguin/LinkedIn
May 26, 2025, 15:55

Farina Arreguin: Chemo-Immunotherapy Has Improved the Care of Patients With Relapsed/Refractory Neuroblastoma

Farina Arreguin, Professor of Pediatric Oncology Subspecialty at ISSSTE National Medical Center, shared a post on X:

“Chemo-Immunotherapy has improved the care of patients with relapsed/refractory neuroblastoma ..”Farina Arreguin

More posts featuring Farina Arreguin.

 

cancer chemo-immunotherapy Farina Arreguin neuroblastoma OncoDaily Oncology
Special Coverage
Blog
Jun 14, 2025, 16:32
Inviting All Members to Take a Brief Survey to Grow and Engage Globally - IASLC
Blog
Jun 14, 2025, 16:16
Investing in Nurses, Saving Young Lives - World Child Cancer
Blog
Jun 14, 2025, 16:01
Ru Xin Wong: Google NotebookLM Can Summarise Articles and Create Podcasts for Listening on the Go
Blog
Jun 14, 2025, 15:50
Paul Hakimata: Discussing the Power of Precision Medicine at GO2 for Lung Cancer Foundation Event
Blog
Jun 14, 2025, 15:38
Join the webinar to learn about the intersection of aging and Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center
Insight
Jun 14, 2025, 14:47
Capstan Therapeutics Announced the Successful Dosing of the First Participants in Capstan’s Phase 1 trial
Insight
Jun 14, 2025, 14:44
Vivek Subbiah: Why Every Rare Cancer Patient Deserves Molecular Profiling?
Science
Jun 14, 2025, 14:15
Thejus Jayakrishnan Shared an Article On What Age Is The Best “FIT” For Colorectal Cancer Screening
Blog
Jun 14, 2025, 13:51
Amol Akhade: Common Drug Interactions with Abiraterone and Enzalutamide
Blog
Jun 14, 2025, 13:45
ESMO Living Guidelines on Renal Cell Carcinoma Are Out
Insight
Jun 14, 2025, 13:44
Nicholas DeVito Was Honored With Junior Faculty Teaching Award
Blog
Jun 14, 2025, 13:43
Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter